Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The c-Kit/SCF signaling axis is a critical pathway for the development and maintenance of various cell lineages, including hematopoietic stem cells, mast cells, melanocytes, and germ cells. The axis is activated when the ligand, Stem Cell Factor (SCF), binds to the extracellular domain of the c-Kit receptor (CD117), a type III receptor tyrosine kinase, leading to receptor dimerization, autophosphorylation, and activation of downstream signaling cascades like PI3K/AKT, MAPK/ERK, and JAK/STAT. Dysregulation of this axis, often through gain-of-function mutations in the KIT gene, is a primary driver in several malignancies, most notably gastrointestinal stromal tumors (GIST) and systemic mastocytosis. Consequently, c-Kit has become a major therapeutic target for small-molecule tyrosine kinase inhibitors (TKIs). While these drugs have revolutionized treatment for KIT-driven cancers, the emergence of secondary resistance mutations remains a significant clinical challenge. Therapeutic strategies now focus on next-generation inhibitors capable of overcoming these resistant variants.
Small molecule inhibition of the intracellular tyrosine kinase domain, preventing autophosphorylation and downstream signaling cascades.
7 more in the full profile.
Source types: Peer-reviewed publication. Sources are available to Gosset users. Log in to see them.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mast/stem cell growth factor receptor Kit (KIT).